Related Experiment Video
Updated: Jan 28, 2026

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
CADM2 inhibits human glioma proliferation, migration and invasion
Nan Liu1, Chen Yang2, Wansheng Bai3
1Department of Experimental Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China.
Abstract:
Malignant glioma is one of the most common malignant tumors in the brain parenchyma with a poor prognosis. Cell adhesion molecules (CADMs) immunoglobulin super family is involved in the maintenance of cell adhesion, polarity and tumor suppression. However, the role and mechanisms of CADM2 in human glioma have yet to be elucidated. Therefore, the present study evaluated the expression level of CADM2 and demonstrated that CADM2 was markedly downregulated in human glioma tissues compared with normal brain tissue and glioma cell lines, and the CADM2 expression level was significantly decreased in high‑grade glioma tissues. Overexpression of CADM2 inhibited the proliferation of glioma cell proliferation in vitro and in vivo. CADM2 also inhibited the migration and invasion of U87 and U251 cells. Furthermore, overexpression of CADM2 induced a significant decrease in the expression of G1/S transition key regulators, cyclin D1, cyclin E, cyclin‑dependent kinase (CDK)2 and CDK4. Additionally, CADM2 expression was associated with alterations in epithelial‑mesenchymal transition (EMT) markers, including E‑cadherin and β‑catenin. Taken together, the results of the present study demonstrated that CADM2 inhibits glioma tumorigenesis by regulating the cell cycle and the EMT process, suggesting that CADM2 may be a novel potential therapeutic target in human glioma.
Insights
Cell adhesion molecule 2 (CADM2) is downregulated in human glioma. Overexpressing CADM2 inhibits glioma cell proliferation, migration, and invasion by regulating the cell cycle and epithelial-mesenchymal transition (EMT).
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cell Biology
Background:
- Malignant glioma is a prevalent brain tumor with a poor prognosis.
- Cell adhesion molecules (CADMs) are implicated in tumor suppression.
- The specific role of CADM2 in human glioma remains unclear.
Purpose of the Study:
- To investigate the expression and function of CADM2 in human glioma.
- To elucidate the mechanisms by which CADM2 affects glioma progression.
Main Methods:
- Quantitative analysis of CADM2 expression in glioma tissues and cell lines.
- In vitro and in vivo studies of CADM2 overexpression effects on glioma cells.
- Analysis of cell cycle regulators and epithelial-mesenchymal transition (EMT) markers.
Main Results:
- CADM2 expression is significantly downregulated in human glioma tissues and cell lines, particularly in high-grade gliomas.
- CADM2 overexpression suppressed glioma cell proliferation, migration, and invasion.
- CADM2 regulated key cell cycle proteins (cyclin D1, E, CDK2, CDK4) and EMT markers (E-cadherin, β-catenin).
Conclusions:
- CADM2 inhibits glioma tumorigenesis through regulation of the cell cycle and EMT.
- CADM2 represents a potential novel therapeutic target for human glioma.
Related Concept Videos
Feedback Inhibition
Abnormal Proliferation
Migration
Enzyme Inhibition
Cell Migration
Cell Migration

